Gestational diabetes. Diabetes mellitus in pregnancy, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Magnesium supplements (21st Century, Arizona, USA), 250 mg, daily, for 6 weeks orally. Intervention 2: Control group: Placebo capsule, daily for 6 weeks orally.
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patients with gestational diabetes Aged 18 to 40 years
Exclusion criteria
Exclusion criteria: Taking magnesium supplements within the past 3 months Needing to insulin therapy during the intervention Pre-eclampsia Eclampsia Hypo and hyperthyroidism Smokers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expressed levels of PPAR-?. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.;Expressed levels of GLUT-1. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expressed levels of LDLR gene. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.;Expressed levels of Lp(a) gene. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jamilian
Arak University of Medical Sciences
Outcome results
None listed